Raymond James & Associates’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.24M Buy
135,956
+20,513
+18% +$336K ﹤0.01% 2153
2024
Q2
$1.89M Sell
115,443
-477,197
-81% -$7.67M ﹤0.01% 2201
2024
Q1
$9.87M Sell
592,640
-240,749
-29% -$3.73M 0.01% 1161
2023
Q4
$12.5M Sell
833,389
-221,105
-21% -$3.21M 0.01% 985
2023
Q3
$15.3M Sell
1,054,494
-22,087
-2% -$330K 0.01% 804
2023
Q2
$16.4M Buy
1,076,581
+20,733
+2% +$311K 0.01% 798
2023
Q1
$16M Buy
1,055,848
+73,643
+7% +$1.09M 0.01% 789
2022
Q4
$13.6M Buy
982,205
+578,157
+143% +$8.16M 0.01% 838
2022
Q3
$5.5M Sell
404,048
-6,308
-2% -$93.7K 0.01% 1314
2022
Q2
$6.01M Buy
410,356
+149,484
+57% +$2.31M 0.01% 1279
2022
Q1
$4.32M Buy
260,872
+126,252
+94% +$2.22M ﹤0.01% 1613
2021
Q4
$2.62M Buy
134,620
+67,518
+101% +$1.31M ﹤0.01% 1979
2021
Q3
$1.35M Sell
67,102
-8,648
-11% -$187K ﹤0.01% 2379
2021
Q2
$1.66M Buy
75,750
+7,057
+10% +$150K ﹤0.01% 2233
2021
Q1
$1.41M Buy
68,693
+51,918
+309% +$1.12M ﹤0.01% 2267
2020
Q4
$365K Buy
+16,775
New +$355K ﹤0.01% 3005

Other funds holding BCAT

Raymond James & Associates's BCAT Position: Q3 2024 in Review

Raymond James & Associates increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 18% in Q3 2024, buying an estimated $336K and bringing the position to 135,956 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

Raymond James & Associates first reported a position in BCAT in Q4 2020 and has held it in 16 quarters since. The position peaked at $16.4M in Q2 2023. 80 funds tracked by Wall St. Rank hold BCAT as of Q3 2024.

  • Raymond James & Associates held 135,956 shares of BlackRock Capital Allocation Term Trust worth $2.24M as of Q3 2024.
  • Raymond James & Associates bought 20,513 BlackRock Capital Allocation Term Trust shares in Q3 2024, an estimated $336K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2153 holding.
  • Raymond James & Associates first reported a position in BlackRock Capital Allocation Term Trust in Q4 2020 and has held it in 16 quarters since.
  • Raymond James & Associates's BlackRock Capital Allocation Term Trust position peaked at $16.4M in Q2 2023.
  • 80 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.